Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Perforating Artery Infarction”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Ended earlyNCT00557921
What this trial is testing

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Cogentus Pharmaceuticals 5,000
Not applicableLooking for participantsNCT07237542
What this trial is testing

Effect of Remote Ischemic Preconditioning on Early Neurological Deterioration in Acute Perforating Artery Infarction

Who this might be right for
Ischemic StrokeRemote Ischaemic Preconditioning
Jinling Hospital, China 910
Post-approval studies (Phase 4)Looking for participantsNCT07111559
What this trial is testing

Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial

Who this might be right for
Lacunar StrokeStrokeIschemic Stroke
Nippon Medical School 500
Post-approval studies (Phase 4)Study completedNCT05310968
What this trial is testing

Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction

Who this might be right for
Branch Atheromatous Disease
Beijing Tiantan Hospital 970
Large-scale testing (Phase 3)Not Yet RecruitingNCT07721545
What this trial is testing

Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction

Who this might be right for
Perforating Artery InfarctionPAI
Neurodawn Pharmaceutical Co., Ltd. 944